# Effect of Perimenstrual Ovarian Steroid Supplementation on Perimenstrual Suicidality

> **NCT03720847** · PHASE4 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 30 (actual)

## Conditions studied

- Suicidal Ideation

## Interventions

- **DRUG:** Estradiol Transdermal Patch 0.1 mg/24 hrs
- **DRUG:** Oral Micronized Progesterone
- **DRUG:** Inactive Clear Patch
- **DRUG:** Placebo capsule

## Key facts

- **NCT ID:** NCT03720847
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-31
- **Primary completion:** 2017-11
- **Final completion:** 2017-11
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03720847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03720847, "Effect of Perimenstrual Ovarian Steroid Supplementation on Perimenstrual Suicidality". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03720847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*